Sensocor Diasys
510(k) K881771
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK881771 | Date12 Jan 1989 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Sensocor(Tm) Diasys
- 510(k) Number
- FDA Product Code
- DXN
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1130
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Sensocor Diasys is a cardiac monitoring device designed for continuous, real-time assessment of cardiac function, specifically targeting hemodynamic parameters such as blood pressure and cardiac output. Classified under product code DXN, it is intended for use in clinical settings to provide critical physiological data for patient management. Its primary function aligns with the Cardiovascular advisory committee classification, supporting diagnostic and therapeutic decision-making in acute care environments.
Supplied as a reusable medical device, the Sensocor Diasys is regulated under FDA 510(k) clearance (K881771) with a decision date of January 12, 1989. It is intended for use in hospital or intensive care settings, where its hemodynamic monitoring capabilities are integrated into patient care protocols. The device’s specifications and regulatory pathway reflect its role in cardiovascular diagnostics, though no additional sterility, MRI safety, or single-use details are provided in the available data.